Wolfgang Miesbach: An Important Topic on How Care for Bleeding Disorders Can Be Organized Across Europe at EAHAD 2026
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
”In Dublin at EAHAD2026, an important topic was not a new drug – but how care for people with bleeding disorders can be organized across Europe.
The EAHAD–EHC accreditation model for European Haemophilia Centres lead by Ana Boban and Fariba Baghaei evolving to:
- Reflect novel therapies and gene therapy within updated centre
- Define clear roles for Comprehensive Care Centres (EHCCC) and Treating Centres (EHTC) in a hub‑and‑spoke
- Introduce structured on‑site and online audits as a permanent part of the accreditation processe
A pilot audit project across several centres tested the feasibility of combining remote and on‑site assessments and showed that audits can be used as a quality‑improvement tool, not just a regulatory exercise.
For patients and families, the EHCCC/EHTC designation means a minimum guaranteed level of multidisciplinary expertise, laboratory support and 24/7 emergency access, wherever they live.”
More from EAHAD 2026 featured in Hemostasis Today.
-
May 27, 2026, 04:47Daniel Torrent: The Overlooked Epidemic of Post-Thrombotic Syndrome
-
May 27, 2026, 04:45Graziella Pompei: Is Aspirin Still a Valid Alternative to Clopidogrel in PCI with DES Implantation?
-
May 27, 2026, 04:40Kausik Ray: Phase 1 Trial Highlights Anti-Inflammatory Effects of Ruvonoflast
-
May 27, 2026, 04:29Francisco Chacón-Lozsán: High-Sensitivity Troponin and the Evolving Management of NSTEMI
-
May 27, 2026, 04:14Michael R. Jaff: HI-PEITHO Trial and NEWS Score Insights on Advances for Intermediate-Risk Pulmonary Embolism
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications
-
May 26, 2026, 15:32Haroun Gajraj: Brown Marks After Microsclerotherapy – What Every Practitioner Needs to Know
-
May 26, 2026, 15:29Jacqueline van Paassen: Lack of Essential Clinical Data in DOAC Prescriptions in Community Pharmacies